M David Mott

Affiliations

  • Director at Epizyme Inc. (EPZM), 2021-10-01
  • Director at Novavax Inc (NVAX), 2021-09-24
  • Director at Ardelyx Inc. (ARDX), 2021-06-21
  • Director at Mersana Therapeutics Inc. (MRSN), 2021-06-15
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2020-07-01
  • Director at Imara Inc. (IMRA), 2020-03-16
  • Large Shareholder at Casper Sleep Inc. (CSPR), 2020-02-06
  • Large Shareholder at Black Diamond Therapeutics Inc. (BDTX), 2020-01-30
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2019-12-26
  • Large Shareholder at Sprout Social Inc. (SPT), 2019-12-18
  • Large Shareholder at Galera Therapeutics Inc. (GRTX), 2019-11-12
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2019-11-04
  • Large Shareholder at Cloudflare Inc. (NET), 2019-09-18
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2019-06-25
  • Large Shareholder, Director at Nightstar Therapeutics Plc (NITE), 2019-06-07
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2019-05-13
  • Large Shareholder at Aveo Pharmaceuticals Inc (AVEO), 2019-04-08
  • Large Shareholder, Director at Tesaro Inc. (TSRO), 2019-01-22
  • Large Shareholder at Ra Pharmaceuticals Inc. (RARX), 2018-12-14
  • Large Shareholder at Millendo Therapeutics Inc. (MLND), 2018-12-12
  • Large Shareholder at Phasebio Pharmaceuticals Inc (PHAS), 2018-10-24
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2018-10-18
  • Large Shareholder at Elastic N.v. (ESTC), 2018-10-10
  • Large Shareholder at Mulesoft Inc (MULE), 2018-05-09
  • Large Shareholder at Surface Oncology Inc. (SURF), 2018-04-23
  • Large Shareholder at Tracon Pharmaceuticals Inc. (TCON), 2018-03-27
  • Large Shareholder at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Large Shareholder at Arca Biopharma Inc. (ABIO), 2018-02-27
  • Large Shareholder at Appian Corp (APPN), 2018-02-15
  • Large Shareholder at Synlogic Inc. (SYBX), 2018-01-26
  • Large Shareholder at Strongbridge Biopharma Plc (SBBP), 2018-01-09
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Care.com Inc (CRCM), 2017-11-09
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-10
  • Large Shareholder at Achaogen Inc (AKAO), 2016-12-19
  • Large Shareholder at Roka Bioscience Inc. (ROKA), 2016-09-30
  • Large Shareholder at Interleukin Genetics Inc (ILIU), 2016-08-02
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Champions Oncology Inc. (CSBR), 2015-03-24
  • Large Shareholder at Box Inc (BOX), 2015-01-29
  • Large Shareholder at Cvent Inc (CVT), 2014-11-28
  • Large Shareholder at Dermira Inc. (DERM), 2014-10-08
  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2014-08-06
  • Large Shareholder at Aerohive Networks Inc (HIVE), 2014-04-03
  • Large Shareholder at Glycomimetics Inc (GLYC), 2014-01-15
  • Large Shareholder, Director at Omthera Pharmaceuticals Inc. (OMTH), 2013-07-18
  • Large Shareholder at Clovis Oncology Inc. (CLVS), 2013-06-05
  • Large Shareholder at Workday Inc. (WDAY), 2013-04-11
  • Large Shareholder at Millennial Media Inc. (MM), 2012-10-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EPZM $7.80 217 Director 150,900 2021-03-26 Filing
EPZM $7.97 34,269 Director 150,683 2021-03-26 Filing
EPZM $7.98 28,231 Director 116,414 2021-03-25 Filing
ARDX $5.89 170,000 Director 417,284 2020-12-10 Filing
EPZM $16.03 62,019 Director 82,601 2020-06-26 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NVAX $255.38 1,200 Director 40,000 2021-09-23 Filing
NVAX $254.46 2,732 Director 41,200 2021-09-23 Filing
NVAX $253.46 7,744 Director 43,932 2021-09-23 Filing
NVAX $252.56 7,557 Director 51,676 2021-09-23 Filing
NVAX $251.32 5,728 Director 59,233 2021-09-23 Filing